These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 23290837)

  • 1. Evaluation of Australia's varicella vaccination program for children and adolescents.
    Ward K; Dey A; Hull B; Quinn HE; Macartney K; Menzies R
    Vaccine; 2013 Feb; 31(10):1413-9. PubMed ID: 23290837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia.
    Gao Z; Gidding HF; Wood JG; MacIntyre CR
    Epidemiol Infect; 2010 Apr; 138(4):457-68. PubMed ID: 19781116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varicella vaccination in Australia and New Zealand.
    Macartney KK; Burgess MA
    J Infect Dis; 2008 Mar; 197 Suppl 2():S191-5. PubMed ID: 18419396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.
    Wutzler P; Neiss A; Banz K; Goertz A; Bisanz H
    Med Microbiol Immunol; 2002 Oct; 191(2):89-96. PubMed ID: 12410347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunisation coverage, 2012.
    Hull BP; Dey A; Menzies RI; Brotherton JM; McIntyre PB
    Commun Dis Intell Q Rep; 2014 Sep; 38(3):E208-31. PubMed ID: 25391407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.
    van Hoek AJ; Melegaro A; Zagheni E; Edmunds WJ; Gay N
    Vaccine; 2011 Mar; 29(13):2411-20. PubMed ID: 21277405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of school entry requirements for varicella vaccination and vaccination coverage 11 years after implementation of the varicella vaccination program.
    Lopez AS; Kolasa MS; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S76-81. PubMed ID: 18419414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster.
    Brisson M; Melkonyan G; Drolet M; De Serres G; Thibeault R; De Wals P
    Vaccine; 2010 Apr; 28(19):3385-97. PubMed ID: 20199763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling the impact of varicella vaccination on varicella and zoster.
    Karhunen M; Leino T; Salo H; Davidkin I; Kilpi T; Auranen K
    Epidemiol Infect; 2010 Apr; 138(4):469-81. PubMed ID: 19796447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of vaccination against varicella in children under 5 years in Puglia, Italy 2006-2012.
    Tafuri S; Fortunato F; Cappelli MG; Cozza V; Bechini A; Bonanni P; Martinelli D; Prato R
    Hum Vaccin Immunother; 2015; 11(1):214-9. PubMed ID: 25483538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy.
    Holl K; Sauboin C; Amodio E; Bonanni P; Gabutti G
    BMC Public Health; 2016 Oct; 16(1):1103. PubMed ID: 27769206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000-2008.
    Chao DY; Chien YZ; Yeh YP; Hsu PS; Lian IB
    Epidemiol Infect; 2012 Jun; 140(6):1131-40. PubMed ID: 21906410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella vaccination in Italy : an economic evaluation of different scenarios.
    Coudeville L; Brunot A; Giaquinto C; Lucioni C; Dervaux B
    Pharmacoeconomics; 2004; 22(13):839-55. PubMed ID: 15329030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near elimination of varicella deaths in the US after implementation of the vaccination program.
    Marin M; Zhang JX; Seward JF
    Pediatrics; 2011 Aug; 128(2):214-20. PubMed ID: 21788222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program.
    Quinn HE; Gidding HF; Marshall HS; Booy R; Elliott EJ; Richmond P; Crawford N; McIntyre PB; Macartney KK;
    J Infect; 2019 Mar; 78(3):220-225. PubMed ID: 30528868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of universal vaccination against varicella in Italy.
    Bechini A; Boccalini S; Baldo V; Cocchio S; Castiglia P; Gallo T; Giuffrida S; Locuratolo F; Tafuri S; Martinelli D; Prato R; Amodio E; Vitale F; Bonanni P
    Hum Vaccin Immunother; 2015; 11(1):63-71. PubMed ID: 25483517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual immunisation coverage report, 2010.
    Hull B; Dey A; Menzies R; McIntyre P
    Commun Dis Intell Q Rep; 2013 Mar; 37(1):E21-39. PubMed ID: 23692156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing evidence of immunity to varicella among children in Massachusetts, 1999-2003.
    Lopez AS; Lett SM; Yih WK; Northrup J; Jumaan AO; Seward JF
    Am J Prev Med; 2006 Mar; 30(3):232-6. PubMed ID: 16476639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of varicella vaccine effectiveness in Germany: a time-series approach.
    Höhle M; Siedler A; Bader HM; Ludwig M; Heininger U; Von Kries R
    Epidemiol Infect; 2011 Nov; 139(11):1710-9. PubMed ID: 21156098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.